Leading Team in Medical Dermatology and Aesthetics
Paul F. Lizzul, MD, PhD
Chief Medical Officer
Dr. Lizzul previously served as Senior Medical Director, Head of Safety and program lead for setipiprant at Kythera Biopharmaceuticals, Inc. from August, 2012 until it was acquired by Allergan in October, 2015.
Prior to joining Kythera, Dr. Lizzul served as an Assistant Professor of Dermatology and Associate Director of Clinical Research at Tufts Medical Center in Boston, MA where he published and conducted numerous clinical studies within psoriasis/psoriatic arthritis. Dr. Lizzul is a diplomat of the American Board of Dermatology and a faculty member of the American Academy of Dermatology. He holds leadership positions within the national dermatology community and also held the distinction of serving on the Food and Drug Administration (FDA) Dermatology and Ophthalmic Drugs Advisory Committee.
Dr. Lizzul is a Summa Cum Laude graduate of Rensselaer Polytechnic Institute, and received his MD, PhD degree in Molecular Genetics and Microbiology, and MPH in Epidemiology/Outcomes from the Rutgers/ Robert Wood Johnson Medical School. Dr. Lizzul also earned an MBA in Entrepreneurship from the Rutgers Business School.